LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 149

Search options

  1. Article: In Regard to Mattes et al.

    Rowley, Jared P / Sindhu, Kunal K / Bakst, Richard L / Buckstein, Michael

    Advances in radiation oncology

    2022  Volume 7, Issue 2, Page(s) 100892

    Language English
    Publishing date 2022-01-04
    Publishing country United States
    Document type Journal Article
    ISSN 2452-1094
    ISSN 2452-1094
    DOI 10.1016/j.adro.2021.100892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy.

    Campbell, Belinda A / Bakst, Richard L / Milgrom, Sarah A / Seymour, John F

    International journal of radiation oncology, biology, physics

    2022  Volume 113, Issue 3, Page(s) 479–488

    MeSH term(s) Humans ; Patient Selection
    Language English
    Publishing date 2022-06-28
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2022.02.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.

    Lester, Scott C / Moon, Dominic H / Patel, Samir H / Awan, Musaddiq J / Bakst, Richard L

    International journal of radiation oncology, biology, physics

    2023  Volume 118, Issue 1, Page(s) 165–168

    MeSH term(s) Humans ; Radiation Dose Hypofractionation ; Head and Neck Neoplasms/radiotherapy ; Employment ; Radiotherapy, Conformal
    Language English
    Publishing date 2023-11-08
    Publishing country United States
    Document type Editorial
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2023.07.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Clinical Outcomes Confirm Conjecture: Modern Radiation Therapy Reduces the Risk of Late Toxicity in Survivors of Hodgkin Lymphoma.

    Milgrom, Sarah A / Bakst, Richard L / Campbell, Belinda A

    International journal of radiation oncology, biology, physics

    2021  Volume 111, Issue 4, Page(s) 841–850

    MeSH term(s) Hodgkin Disease/drug therapy ; Hodgkin Disease/radiotherapy ; Humans ; Risk Factors ; Survivors
    Language English
    Publishing date 2021-10-14
    Publishing country United States
    Document type Editorial
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2021.06.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Close Margins After Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Carcinoma: A Review of the Literature and Practical Recommendations.

    Berlin, Eva / Ma, Daniel J / Bakst, Richard L / Quon, Harry / Lin, Alexander / Lukens, J Nicholas

    Practical radiation oncology

    2023  Volume 13, Issue 3, Page(s) 251–255

    Abstract: The purpose of this article is to summarize the literature and practical recommendations from experienced centers for close margins after transoral robotic surgery for human papillomavirus-positive oropharyngeal carcinoma. ...

    Abstract The purpose of this article is to summarize the literature and practical recommendations from experienced centers for close margins after transoral robotic surgery for human papillomavirus-positive oropharyngeal carcinoma.
    MeSH term(s) Humans ; Human Papillomavirus Viruses ; Robotic Surgical Procedures ; Carcinoma, Squamous Cell/pathology ; Oropharyngeal Neoplasms/surgery ; Oropharyngeal Neoplasms/pathology ; Retrospective Studies
    Language English
    Publishing date 2023-01-01
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 2655748-4
    ISSN 1879-8519 ; 1879-8500
    ISSN (online) 1879-8519
    ISSN 1879-8500
    DOI 10.1016/j.prro.2022.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Prognostic implications of HER2NEU-low in metastatic breast cancer.

    Neubauer, Zachary / Hasan, Shaakir / Press, Robert H / Chhabra, Arpit M / Fox, Jana / Bakst, Richard / Simone, Charles B / Choi, J Isabelle

    Cancer medicine

    2024  Volume 13, Issue 2, Page(s) e6979

    Abstract: Introduction: We explored characteristics and clinical outcomes of HER2-negative and HER2-low metastatic breast cancers using real-world data.: Methods: We queried the National Cancer Database to identify MBC patients that were HER2-low or HER2- ... ...

    Abstract Introduction: We explored characteristics and clinical outcomes of HER2-negative and HER2-low metastatic breast cancers using real-world data.
    Methods: We queried the National Cancer Database to identify MBC patients that were HER2-low or HER2-negative per immunohistochemical staining. A binomial regression analysis identified demographic and clinical correlates of each subtype. A Cox multivariable regression analysis (MVA) and propensity-match analysis were performed to identify correlates of survival.
    Results: Excluding missing data, 24,636 MBC patients diagnosed between 2008 and 2015 were identified; 27.9% were HER2-negative and 72.1% were HER2-low. There were no relevant demographic differences between the groups. HER2-low tumors were half as likely to have concomitant hormone receptor-positive status (p < 0.01). The 3-year survival rate among hormone receptor-negative patients was 33.8% for HER2-low and 32.2% for HER2-negative (p < 0.05), and 60.9% and 55.6% in HER2-low and HER2-negative cases among hormone receptor-positive patients (p < 0.05), respectively. HER2-low cases were associated with better survival on MVA (HR =0.95, 95% CI 0.91-0.99) and remained superior with propensity-matching (HR = 0.92, 95% CI 0.89-0.96). In a subset analysis isolated to hormone receptor-positive cases, HER2-low remained correlated with improved survival (HR = 0.93, 95% CI 0.89-0.98) with propensity-matched MVA. Correlates of worse survival include older age as a continuous variable (HR = 1.02, 95% CI 1.02-1.02) and Black race (HR = 1.26, 95% CI 1.20-1.32) [all p < 0.01].
    Conclusions: In the largest such analysis performed to date, our study demonstrates a small but statistically significant association with improved survival for HER2-low tumors compared to HER2-negative tumors in MBC.
    MeSH term(s) Humans ; Female ; Breast Neoplasms/pathology ; Prognosis ; Receptor, ErbB-2/analysis
    Chemical Substances Receptor, ErbB-2 (EC 2.7.10.1)
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2659751-2
    ISSN 2045-7634 ; 2045-7634
    ISSN (online) 2045-7634
    ISSN 2045-7634
    DOI 10.1002/cam4.6979
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Promoting exercise in patients with cancers of the head and neck during COVID-19 and beyond.

    Sindhu, Kunal K / Nehlsen, Anthony D / Bakst, Richard L

    BMJ open sport & exercise medicine

    2021  Volume 7, Issue 1, Page(s) e001024

    Abstract: In recent years, the benefits of exercise in patients with cancer have increasingly been recognised. Unfortunately, patients with, and survivors of, cancers of the head and neck often face a constellation of symptomatic and nutritional obstacles that can ...

    Abstract In recent years, the benefits of exercise in patients with cancer have increasingly been recognised. Unfortunately, patients with, and survivors of, cancers of the head and neck often face a constellation of symptomatic and nutritional obstacles that can interfere with their ability to adhere to structured exercise regimens. The spread of COVID-19 has only added to these challenges. In this Viewpoint, the authors detail the impediments faced by patients with cancers of the head and neck in obtaining sufficient exercise, review the evidence supporting the benefits of exercise in patients with cancer and discuss interventions to promote exercise in this patient population.
    Language English
    Publishing date 2021-03-17
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2817580-3
    ISSN 2055-7647
    ISSN 2055-7647
    DOI 10.1136/bmjsem-2020-001024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer.

    Dickstein, Daniel R / Powers, Ann E / Vujovic, Dragan / Roof, Scott / Bakst, Richard L

    Clinical interventions in aging

    2023  Volume 18, Page(s) 409–422

    Abstract: Approximately 30% of patients with head and neck squamous cell carcinoma (HNSCC) are at least 70 years of age, and this percentage is expected to increase as the population increases and lives longer. Elderly patients are underrepresented in head and ... ...

    Abstract Approximately 30% of patients with head and neck squamous cell carcinoma (HNSCC) are at least 70 years of age, and this percentage is expected to increase as the population increases and lives longer. Elderly patients are underrepresented in head and neck oncology clinical trials, and there is minimal evidence on the management of HNSCC for this population. Subsequently, despite their best intentions, physicians may unknowingly recommend an ill-suited course of therapy, which may result in suboptimal oncological or functional outcomes or adverse events. Surgical approaches have the potential to carry a higher risk of morbidity and mortality in older adults, especially in patients with multiple comorbidities. Definitive radiation therapy treatment in patients with HNSCC frequently involves 7 weeks of daily radiation, sometimes with concurrent chemotherapy, and this demanding treatment can be difficult for older adult patients, which may lead to treatment interruptions, potential removal of concurrent systemic therapy, compromised outcomes, and diminished quality of life. There are clinical trials currently underway investigating altered fractionation regimens and novel, less toxic systemic treatments in this population. This review provides an overview of how best to approach an older adult with HNSCC, from initial work-up to treatment selection.
    MeSH term(s) Humans ; Aged ; Squamous Cell Carcinoma of Head and Neck/therapy ; Carcinoma, Squamous Cell/pathology ; Quality of Life ; Head and Neck Neoplasms/therapy ; Patient Selection
    Language English
    Publishing date 2023-03-17
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2364924-0
    ISSN 1178-1998 ; 1176-9092
    ISSN (online) 1178-1998
    ISSN 1176-9092
    DOI 10.2147/CIA.S366155
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Rapid cancer cell perineural invasion utilizes amoeboid migration.

    Marcadis, Andrea R / Kao, Elizabeth / Wang, Qi / Chen, Chun-Hao / Gusain, Laxmi / Powers, Ann / Bakst, Richard L / Deborde, Sylvie / Wong, Richard J

    Proceedings of the National Academy of Sciences of the United States of America

    2023  Volume 120, Issue 17, Page(s) e2210735120

    Abstract: The invasion of nerves by cancer cells, or perineural invasion (PNI), is potentiated by the nerve microenvironment and is associated with adverse clinical outcomes. However, the cancer cell characteristics that enable PNI are poorly defined. Here, we ... ...

    Abstract The invasion of nerves by cancer cells, or perineural invasion (PNI), is potentiated by the nerve microenvironment and is associated with adverse clinical outcomes. However, the cancer cell characteristics that enable PNI are poorly defined. Here, we generated cell lines enriched for a rapid neuroinvasive phenotype by serially passaging pancreatic cancer cells in a murine sciatic nerve model of PNI. Cancer cells isolated from the leading edge of nerve invasion showed a progressively increasing nerve invasion velocity with higher passage number. Transcriptome analysis revealed an upregulation of proteins involving the plasma membrane, cell leading edge, and cell movement in the leading neuroinvasive cells. Leading cells progressively became round and blebbed, lost focal adhesions and filipodia, and transitioned from a mesenchymal to amoeboid phenotype. Leading cells acquired an increased ability to migrate through microchannel constrictions and associated more with dorsal root ganglia than nonleading cells. ROCK inhibition reverted leading cells from an amoeboid to mesenchymal phenotype, reduced migration through microchannel constrictions, reduced neurite association, and reduced PNI in a murine sciatic nerve model. Cancer cells with rapid PNI exhibit an amoeboid phenotype, highlighting the plasticity of cancer migration mode in enabling rapid nerve invasion.
    MeSH term(s) Mice ; Animals ; Amoeba ; Pancreatic Neoplasms/genetics ; Sciatic Nerve/metabolism ; Pancreas/metabolism ; Nerve Tissue/metabolism ; Cell Movement/genetics ; Neoplasm Invasiveness ; Tumor Microenvironment
    Language English
    Publishing date 2023-04-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2210735120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: PET Guided Therapy for Early Stage Hodgkin Lymphoma: Are We Positive About a Negative Interim Scan?

    Bakst, Richard L / Campbell, Belinda A / Pinnix, Chelsea C

    International journal of radiation oncology, biology, physics

    2020  Volume 107, Issue 1, Page(s) 12–17

    MeSH term(s) Fluorodeoxyglucose F18 ; Hodgkin Disease ; Humans ; Positron-Emission Tomography
    Chemical Substances Fluorodeoxyglucose F18 (0Z5B2CJX4D)
    Language English
    Publishing date 2020-03-04
    Publishing country United States
    Document type Journal Article ; Review ; Comment
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2020.02.635
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top